Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

about

Cancer, ageing, multimorbidity and primary care.

P2860

Q51822983-0218B87C-5D92-42DE-8DDE-87A84FA9E330

P2860

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

Item

http://www.wikidata.org/entity/Q36018326

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

@ast

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

@en

type

Item

label

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

@ast

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

@en

prefLabel

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

@ast

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

@en

P1476

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

@en

P2093

Huimin Wang

http://www.w3.org/2001/XMLSchema#string

Jinsheng Zhao

http://www.w3.org/2001/XMLSchema#string

Lin Zhao

http://www.w3.org/2001/XMLSchema#string

Xiangyu Sun

http://www.w3.org/2001/XMLSchema#string

Xiuju Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring inconsistency in meta-analyses

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma.

The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study.

Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?

Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.

Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer.

P304

629-636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/JDI.12472

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

288932520

http://www.w3.org/2001/XMLSchema#string

P698

27181717

http://www.w3.org/2001/XMLSchema#string

P932

4931216

http://www.w3.org/2001/XMLSchema#string

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

about

P2860

P2860

Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932